Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

M Kocova, V Anastasovska, H Falhammar - Endocrine, 2020 - Springer
Despite numerous studies in the field of congenital adrenal hyperplasia (CAH) due to 21-
hydroxylase deficiency, some clinical variability of the presentation and discrepancies in the …

Characteristics of In2G variant in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

M Kocova, P Concolino, H Falhammar - Frontiers in endocrinology, 2022 - frontiersin.org
Substantial research has been performed during the last decades on the clinical and genetic
variability of congenital adrenal hyperplasia (CAH) and its most common form, 21 …

Testicular adrenal rest tumors in congenital adrenal hyperplasia—Cross-sectional study of 51 Croatian male patients

M Dumic, V Duspara, Z Grubic, SK Oguic… - European journal of …, 2017 - Springer
Testicular adrenal rest tumors (TARTs) are common cause of infertility in males with
congenital adrenal hyperplasia (CAH). We studied the role of genotype and disease …

Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort

R Wang, X Luo, Y Sun, L Liang, A Mao… - The Journal of …, 2025 - academic.oup.com
Context Genetic testing for 21-hydroxylase deficiency (21-OHD) is always challenging. The
current approaches of short-read sequencing and multiplex ligation-dependent probe …

Genetic characterization of a cohort of Italian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

P Concolino, A Perrucci, C Carrozza… - Molecular Diagnosis & …, 2023 - Springer
Introduction Defects in the steroid 21-hydroxylase gene (CYP21A2) cause 21-hydroxylase
deficiency (21OHD), the main cause of congenital adrenal hyperplasia (CAH). The disease …

Clinical application of a novel next generation sequencing assay for CYP21A2 gene in 310 cases of 21- hydroxylase congenital adrenal hyperplasia from India

P Gangodkar, V Khadilkar, P Raghupathy, R Kumar… - Endocrine, 2021 - Springer
Purpose Accurate diagnosis is required for management of Congenital adrenal hyperplasia
(CAH). The conventional method for detection of mutations in the CYP21A2 gene is targeted …

[HTML][HTML] Genetic analysis and novel variation identification in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Y Xia, P Shi, S Gao, N Liu, H Zhang, X Kong - The Journal of Steroid …, 2022 - Elsevier
Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency is an autosomal-
recessive disorder caused by mutations in the CYP21A2 gene. The aim of the study was to …

Prenatal diagnosis of steroid 21-hydroxylase-deficient congenital adrenal hyperplasia: Experience from a tertiary care centre in India

S Dubey, V Tardy, MR Chowdhury… - Indian Journal of …, 2017 - journals.lww.com
Methods: Fifteen pregnant women at risk of having an affected offspring with CAH were
included in this study. Ten families had previous affected children with salt-wasting/simple …

Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China

L Su, XI Yin, J Cheng, Y Cai, D Wu, Z Feng, LI Liu - Clinica Chimica Acta, 2018 - Elsevier
Abstract Classical 21-hydroxylase deficiency (21-OHD) due to mutations in the cytochrome
P450 family 21 subfamily A member 2 (CYP21A2) gene is the most common type of …

21-hydroxylase deficiency: mutational spectrum and genotype–phenotype relations analyses by next-generation sequencing and multiplex ligation-dependent probe …

I Turan, M Tastan, DD Boga, F Gurbuz, LD Kotan… - European Journal of …, 2020 - Elsevier
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is
autosomal recessive disorder of cortisol biosynthesis. Genetic defects in CYP21A2 cause …